Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Audited results deadline Feb 28

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Feb 27, 2024 6:06pm

79 Views

Post# 35902620

RE:Audited results deadline Feb 28

If they received a milestone payment that would signal a material development in the AbbVie contract and require a news release. Unless of course they were asked to stay silent in which case it would be a note in the financials.

<< Previous

Bullboard Posts

Next >>

Canadian rare earths stock up as drilling starts at uranium property